Effects of Overexpression of Neurosecretory Protein GL-Precursor Gene on Glucose Homeostasis and Insulin Sensitivity in Mice.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
28 Apr 2021
Historique:
received: 27 03 2021
revised: 24 04 2021
accepted: 26 04 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 9 6 2021
Statut: epublish

Résumé

A high-fat diet (HFD) quickly induces obesity with insulin resistance and hyperglycemia. We previously reported that a novel hypothalamic small protein, named neurosecretory protein GL (NPGL), stimulates feeding and fat accumulation in mice. However, the effects of NPGL on insulin sensitivity and glucose homeostasis remain unknown. Hence, we subjected NPGL-precursor gene (

Identifiants

pubmed: 33925193
pii: ijms22094681
doi: 10.3390/ijms22094681
pmc: PMC8125475
pii:
doi:

Substances chimiques

Blood Glucose 0
Insulin 0
Nerve Tissue Proteins 0
Neuropeptides 0
neurosecretory protein GL, mouse 0
Glucose IY9XDZ35W2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : JSPS KAKENHI Grant
ID : JP20K22741 to K.F., JP19K06768 to E.I.-U., and JP19H03258 to K.U.
Organisme : the Takeda Science Foundation
ID : none
Organisme : the Uehara Memorial Foundation
ID : none
Organisme : the Ono Medical Research Foundation
ID : none

Références

Nat Rev Genet. 2017 Dec;18(12):731-748
pubmed: 28989171
J Neurosci. 2014 Apr 16;34(16):5486-96
pubmed: 24741039
Cell Metab. 2017 Aug 1;26(2):324-341
pubmed: 28768172
Nat Rev Neurosci. 2014 Jun;15(6):367-78
pubmed: 24840801
Neuron. 2017 Aug 16;95(4):757-778
pubmed: 28817798
Nature. 1994 Dec 1;372(6505):425-32
pubmed: 7984236
Nature. 2006 Sep 21;443(7109):289-95
pubmed: 16988703
J Clin Invest. 2005 Oct;115(10):2843-54
pubmed: 16184193
Diabetes. 2001 Nov;50(11):2438-43
pubmed: 11679419
NMR Biomed. 2009 Apr;22(3):310-7
pubmed: 19012281
Biosci Biotechnol Biochem. 2021 Apr 14;:
pubmed: 33851987
Science. 1996 Feb 2;271(5249):665-8
pubmed: 8571133
Elife. 2017 Aug 11;6:
pubmed: 28799896
Physiol Rev. 2018 Oct 1;98(4):2133-2223
pubmed: 30067154
Front Neuroendocrinol. 2020 Jan;56:100801
pubmed: 31705911
Neuron. 2003 Feb 20;37(4):649-61
pubmed: 12597862
Cell Metab. 2016 Feb 9;23(2):335-43
pubmed: 26724858
Am J Physiol Endocrinol Metab. 2008 Dec;295(6):E1323-32
pubmed: 18812462
Science. 2005 Jan 21;307(5708):375-9
pubmed: 15662002
Gen Comp Endocrinol. 2018 Jan 15;256:37-42
pubmed: 28554734
Neuron. 2011 Jul 14;71(1):142-54
pubmed: 21745644
J Endocrinol. 2020 Jan 1;244(1):1-12
pubmed: 31536964
Physiol Behav. 2020 Oct 1;224:113039
pubmed: 32610101
Neuron. 2017 Oct 11;96(2):461-475.e5
pubmed: 29024666
Lancet. 2005 Oct 1;366(9492):1197-209
pubmed: 16198769
Endocrinology. 2005 Mar;146(3):1043-7
pubmed: 15591135
Cell Rep. 2018 Jan 16;22(3):706-721
pubmed: 29346768
Ann N Y Acad Sci. 2017 Mar;1391(1):35-53
pubmed: 27768821
Science. 1993 Jan 1;259(5091):87-91
pubmed: 7678183
J Vis Exp. 2018 Jan 7;(131):
pubmed: 29364280
Gen Comp Endocrinol. 2018 May 1;260:164-170
pubmed: 28951261
Biochem Biophys Res Commun. 2014 Mar 28;446(1):298-303
pubmed: 24582750
Sci Rep. 2019 Apr 16;9(1):6156
pubmed: 30992489
Nat Commun. 2017 May 04;8:15259
pubmed: 28469281
Cell Metab. 2016 Feb 9;23(2):344-9
pubmed: 26724861
J Endocrinol. 2008 Apr;197(1):181-7
pubmed: 18372244
J Lipid Res. 2014 Dec;55(12):2541-53
pubmed: 25271296
Front Endocrinol (Lausanne). 2019 Jun 19;10:392
pubmed: 31275247
Sci Rep. 2018 Jan 15;8(1):704
pubmed: 29335496
Endocrinology. 2017 May 1;158(5):1120-1129
pubmed: 28323972
Nature. 2001 May 24;411(6836):480-4
pubmed: 11373681
Annu Rev Psychol. 2008;59:55-92
pubmed: 18154499
Nature. 2001 Jan 11;409(6817):194-8
pubmed: 11196643
J Clin Invest. 2003 Dec;112(12):1796-808
pubmed: 14679176
J Clin Invest. 2008 Jun;118(6):2132-47
pubmed: 18451994
Pharmacoeconomics. 2015 Jul;33(7):673-89
pubmed: 25471927

Auteurs

Keisuke Fukumura (K)

Laboratory of Neurometabolism, Graduate School of Integrated Sciences for Life, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8521, Japan.

Yuki Narimatsu (Y)

Laboratory of Neurometabolism, Graduate School of Integrated Sciences for Life, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8521, Japan.

Shogo Moriwaki (S)

Laboratory of Neurometabolism, Graduate School of Integrated Sciences for Life, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8521, Japan.

Eiko Iwakoshi-Ukena (E)

Laboratory of Neurometabolism, Graduate School of Integrated Sciences for Life, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8521, Japan.

Megumi Furumitsu (M)

Laboratory of Neurometabolism, Graduate School of Integrated Sciences for Life, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8521, Japan.

Kazuyoshi Ukena (K)

Laboratory of Neurometabolism, Graduate School of Integrated Sciences for Life, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8521, Japan.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH